RBC Europe’s Q32 Bio QTTB Stock Holding History

RBC Europe’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11	Closed	-$1.59K	–	1179
2021 Q3	$1.59K	Hold	11	–	–	﹤0.01%	1153
2021 Q2	$1.47K	Hold	11	–	–	﹤0.01%	1157
2021 Q1	$1.9K	Hold	11	–	–	﹤0.01%	1083
2020 Q4	$2.28K	Hold	11	–	–	﹤0.01%	1038
2020 Q3	$2.16K	Buy	+11	New	+$2.46K	﹤0.01%	978

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RBC Europe's QTTB Position: Q4 2021 in Review

RBC Europe sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 11 shares — an estimated $1.59K sold.

RBC Europe first reported a position in QTTB in Q3 2020 and held it in 5 quarters. The position peaked at $2.28K in Q4 2020. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

RBC Europe reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 11 Q32 Bio shares in Q4 2021, an estimated $1.59K.
RBC Europe first reported a position in Q32 Bio in Q3 2020 and held it in 5 quarters.
RBC Europe's Q32 Bio position peaked at $2.28K in Q4 2020.
120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.